JAK2 and breast carcinoma: The operation of TPH1-5-HT-5-HT7 axis utilized PI3K/Akt and JAK2/STAT3 signaling pathways that were activated through Gβγ components of the receptor, consistent with our previous findings in breast cancer cells [28].